At Spine Summit (booth #228) and
- Spine Summit: Special course, Innovations in Spine, will feature product demos of the Pulse platform on
March 16from 1:30 to 4:30 p.m. ET. IMAST: NuVasive-hosted workshop, Intelligent Surgery for Complex Spine, will feature Drs. David Okonkwoand Justin Smithas they review technology-driven strategies and tools to maximize outcomes for challenging spine cases on March 23from 12:15 to 1:15 p.m. GMT.
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-participate-in-upcoming-spine-society-annual-conferences-301770790.html
Investor contact: Juliet C. Cunningham, NuVasive, Inc., 858-210-2129, firstname.lastname@example.org; Media contact: Melanie Ordoñez, NuVasive, Inc., 858-722-3899, email@example.com